Because E2 increases MB tumor survival through a general cytoprotective mechanism by increasing IGF-signaling [27], we hypothesized that its cytoprotective effects would decrease the cytotoxic effects of chemotherapeutic agents used for MB treatment independent of their mechanism of action. The gene discussed is IGF1; the disease is neoplasm.